News | July 22, 2023
Merck receives positive European Union CHMP opinion for Gefapixant
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Its a major breakthrough for women’s ovarian cancer care in Europe
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
Subscribe To Our Newsletter & Stay Updated
